Constellation Pharmaceuticals, Inc.
Constellation Pharmaceuticals, Inc.(Constellation) is a pharmaceutical company, engaged in the development of therapeutics in the area of epigenetics. Epigenetics is an area that involves chemical changes of DNA and its packaging proteins, together known as the epigenome. The company is principally focused on oncology, and its epigenetics platform will also be used to develop therapeutics for autoimmune, inflammatory and neurological diseases. Constellation is building the premier chromatin therapeutics company through the discovery and development of drugs targeting epigenetic function and associated disease biology. The Company is also building a technology platform to expeditiously and simultaneously explore multiple targets in multiple therapeutic areas. Constellation is headquartered in Cambridge, the US.